Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 8/26/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Weibing Lu

Wrong Weibing Lu?

Chairman and Chief Executive Offi...

Phone: +86 ** ********  HQ Phone
Email: l***@***.com
Local Address:  China
Skystar Bio-Pharmaceutical Company
4/F Building B Chuangye Square No 48 Keji Road
Xi'an , Shaanxi 710065

Company Description: Skystar Bio-Pharmaceutical Company ("Skystar" or the "Company") (Nasdaq: SKBI) Skystar Bio-Pharmaceutical Company was founded in 1997. Skystar has grown to become...   more

Employment History

96 Total References
Web References
NASDAQ:SKBI News - Skystar to Launch Probiotic Supplement for Dairy Cows by End of Fiscal 2014 - Virmmac | Virtual IR, Marketing, Media and Administration Center, 26 Aug 2014 [cached]
Mr. Weibing Lu, Chairman and CEO of Skystar, commented, "Skystar's dairy cow probiotic is expected to launch at the end of the fiscal year and is a welcome addition to Skystar's Western medicine-based line of animal husbandry products.
Weibing Lu - Chairman and ..., 16 May 2014 [cached]
Weibing Lu - Chairman and Chief Executive Officer
Bing Mei - Chief Financial Officer
Joining us on the call today is Skystar's Chairman and CEO, Weibing Lu, Skystar's CFO Bing Mei and Director of Corporate Development and U.S.
On behalf of Mr. Lu, Chairman and CEO and the rest of Skystar's management team, I would like to say good morning for those callers joining us here locally and good evening to those who are in China or elsewhere in the world.
Speaking of behalf of Mr. Lu, I would like to share his comments for the quarter. So Mr. Lu, Chairman and Chief Executive Officer of Skystar commented, the company has achieved significant milestones in preparing two of its manufacturing facilities to become fully operational.
Joining us on the call today ..., 16 May 2014 [cached]
Joining us on the call today is Skystar's Chairman and CEO Weibing Lu, Skystar's CFO Bing Mei and company's Director of Corporate Development and US Representative Scott Cramer.
I will be delivering prepared comments today on behalf of Mr. Lu, our Chairman and CEO of Skystar who will be available for Q&A after the opening remarks.
Joining us on the call today ..., 16 May 2014 [cached]
Joining us on the call today is Skystar's Chairman and CEO, Weibing Lu; Skystar's CFO Bing Mei; and Director of Corporate Development and U.S.
On behalf of Mr. Lu, Chairman and CEO, and the rest of Skystar's management team, I wish to say good evening to everyone.
As usual, today I'll be speaking from prepared comments on behalf of Mr. Lu who unfortunately due to technical difficulties in China, we can't seem to keep the connections established and he keeps being dropped from the call. But we do have Bing Mei, our CFO, on the call and Mr. Lu may be joining back in if we can re-establish the call.
Collectively, we will be sharing the company's comments for this particular strong recent quarter. We believe the quarter sets a milestone in moving forward as Skystar so we can get back on the production track again. Some of our production facilities now have the GMP Certification along with some of the accompanying product production permits that have been approved by the government.
Mr. Lu, Chairman and Chief Executive Officer of Skystar, commented on the quarter. He is very pleased to report that it's the strongest quarterly results in the last six reporting periods.
Mr. Weibing Lu, Chairman and ..., 16 May 2014 [cached]
Mr. Weibing Lu, Chairman and Chief Executive Officer of Skystar (SKBO), commented, "Skystar is pleased with unaudited first quarter results seeing increases in both year over year top and bottom line profitability. Skystar's revenue growth was driven by Veterinary medicine which grew 40% year over year with solid contributions coming from Skystar's other segments. The increased utilization rates for Skystar's veterinary medication production facility were realized following the receipt of more product permits from the Ministry of Agriculture. Skystar's YoY gross margin compression from 47% to 41% for the current reporting quarter was anticipated due to increased production coming from the lower margin veterinary medications line for which the Company recently received some product permits, and increased manufacturing overhead as we successfully completed our Huxian vaccine plant construction. We expect for manufacturing to continue to scale up throughout the year in preparation for the majority of Skystar's sales coming after the first quarter coinciding with China's celebration of the Lunar New Year holiday. Skystar expects a steady growth trajectory once all of its manufacturing plants can be completed and brought to full utilization rates," concluded Mr. Lu.
Mr. Lu concluded, "Skystar has reported a strong start to the fiscal 2014 reporting cycle. The Company believes that it has built a strong framework as the only U.S. listed animal pharmaceutical play in China. The completed and newly GMP certified manufacturing facility in Huxian gives Skystar the ability to produce veterinary medicines and vaccines utilizing modern batch processes, increasing production efficiencies and volume of product produced. More importantly, the Company has been able to launch and expand infrastructure within the tougher regulatory framework of China's new requirements for GMP production facilities. These modern manufacturing standards and rules help to ensure the safety of China's food supply as agriculture and animal husbandry standards in China move towards modern standards and industrialization," concluded Mr. Lu.
Mr. Weibing Lu, Skystar's chairman and chief executive officer, will host the call, which will be webcast live.
Other People with the name "Lu":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.